Weaver, Terri E. http://orcid.org/0000-0002-4680-5766
Menno, Diane M.
Bron, Morgan
Crosby, Ross D.
Morris, Susan
Mathias, Susan D.
Funding for this research was provided by:
Jazz Pharmaceuticals
Article History
Received: 22 September 2020
Revised: 18 November 2020
Accepted: 8 December 2020
First Online: 4 January 2021
Compliance with ethical standards
:
: TEW has received royalty fees for the use of the FOSQ-10 from Jazz Pharmaceuticals, ResMed, Bayer AD, Cook Medical, Nyxoah, RWS, Merck & Co. Inc., Verily Life Science, WCG MedAvante Prophase, Stratevi, Evidation Health, and Philips Respironics. RDC is a consultant to Health Outcomes Solutions, which received funding from Jazz Pharmaceuticals for conducting these analyses. DMM, MB, and SM are employees of Jazz Pharmaceuticals who, in the course of their employment, have received stock options exercisable for, and other stock awards of, ordinary shares of Jazz Pharmaceuticals, LLC. SDM is an employee of Health Outcomes Solutions, which received funding from Jazz Pharmaceuticals for conducting these analyses.
: These studies were conducted in line with the principles of the Declaration of Helsinki and were approved by institutional review board or ethics committees at each site.
: All participants provided written informed consent.
: All authors granted final approval of the manuscript for submission.
: Not applicable.